You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroretentive drug formulation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Grayslake (Venetoclax)

Recruiting
  • Healthy Volunteers
  • Grayslake, Illinois
    Acpru /Id# 259897
Oct 2, 2023

Healthy Trial (Drug: PF-07817883)

Not yet recruiting
  • Healthy
  • Drug: PF-07817883
  • (no location specified)
Nov 2, 2023

Healthy Volunteers Trial in Daytona Beach (Iberdomide)

Recruiting
  • Healthy Volunteers
  • Daytona Beach, Florida
    Labcorp Clinical Research Unit, Inc. - Daytona Beach
Jun 9, 2023

COVID-19 Trial in London (ALG-097558, Placebo, Midazolam)

Not yet recruiting
  • COVID-19
  • London, United Kingdom
    Hammersmith Medicines Research
Apr 21, 2023

Healthy Adult Volunteers Trial (BMS-986196)

Not yet recruiting
  • Healthy Adult Volunteers
  • (no location specified)
Sep 6, 2023

Healthy Volunteers Trial (Danicamtiv)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Aug 31, 2023

Healthy Participants Trial (BMS-986465, Placebo, Pegasys)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Nov 17, 2023

Healthy Volunteers Trial in Miami (Branebrutinib, Placebo)

Recruiting
  • Healthy Volunteers
  • Miami, Florida
    Syneos Health Clinical Research Services, Llc
May 2, 2022

Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and

Recruiting
  • Bioequivalence
  • Schizophrenia
  • Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023

Healthy Participants Trial in Millcreek, Salt Lake City (BMS-986196, Placebo)

Recruiting
  • Healthy Participants
  • Millcreek, Utah
  • +1 more
Jan 12, 2022

Hypersensitivity Trial in Gainesville (Mometasone furoate drug formulation (MFF) 1, Mometasone furoate drug formulation (MFF) 2)

Completed
  • Hypersensitivity
  • Mometasone furoate drug formulation (MFF) 1
  • Mometasone furoate drug formulation (MFF) 2
  • Gainesville, Florida
    Department of Pharmaceutics, University of Florida
Nov 15, 2021

COVID-19 Trial (CG-SpikeDown, intranasal formulation, Vehicle (Placebo), Standard of core (type of therapy is depend of decide

Not yet recruiting
  • Healthy
  • CG-SpikeDown, intranasal formulation
  • +2 more
  • (no location specified)
Sep 20, 2022

Normal Healthy Volunteers Trial in Las Vegas (Lofexidine (granules for reconstitution), LUCEMYRA (lofexidine) tablets)

Completed
Has Results
  • Normal Healthy Volunteers
  • Lofexidine (granules for reconstitution)
  • LUCEMYRA (lofexidine) tablets
  • Las Vegas, Nevada
    Novum Pharmaceutical Research Services
May 19, 2022

Healthy Volunteers Trial in United States (Risankizumab Dose A, Risankizumab Dose B)

Active, not recruiting
  • Healthy Volunteers
  • Risankizumab Dose A
  • Risankizumab Dose B
  • Anaheim, California
  • +4 more
Jan 12, 2023

Healthy Volunteers, Type 2 Diabetes Trial in Berlin (Oral semaglutide)

Completed
  • Healthy Volunteers
  • Type 2 Diabetes
  • Oral semaglutide
  • Berlin, Germany
    Novo Nordisk Investigational Site
Sep 27, 2021

Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters:

Completed
Has Results
  • Hyperlipidemia
  • Omega-3 fatty acid ethyl esters
  • Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
  • Osaka, Japan
  • +1 more
Dec 2, 2021

Bioequivalence Trial in Chennai (Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet, Estradiol Valerate and Dienogest

Completed
  • Bioequivalence
  • Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet
  • Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Apr 11, 2022

Bioequivalence Trial in Chennai (Levodopa 250mg and Carbidopa 25mg Test Drug tablet, Levodopa 250mg and Carbidopa 25mg Referent

Completed
  • Bioequivalence
  • Levodopa 250mg and Carbidopa 25mg Test Drug tablet
  • Levodopa 250mg and Carbidopa 25mg Referent Product tablet
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Mar 7, 2022

HIV Trial in New Zealand, United States (Cabotegravir sodium (Oral Lead In), Cabotegravir 400 mg/mL, Cabotegravir 200 mg/mL)

Recruiting
  • HIV Infections
  • Cabotegravir sodium (Oral Lead In)
  • +6 more
  • Orlando, Florida
  • +4 more
Mar 29, 2022

Arthroplasty, Replacement, Knee, Analgesia Trial in Xi'an (New local anesthesia injection site and new local anesthetic drug

Recruiting
  • Arthroplasty, Replacement, Knee
  • Analgesia
  • New local anesthesia injection site and new local anesthetic drug formulation.
  • Xi'an, Shanxi, China
    Department of Orthopedics, Xijing Hospital, The Air Force Medica
Jan 19, 2022

Bioequivalence Trial in Chennai (Oseltamivir 75mg Test Drug capsules, Oseltamivir 75mg capsules Reference Product capsules)

Completed
  • Bioequivalence
  • Oseltamivir 75mg Test Drug capsules
  • Oseltamivir 75mg capsules Reference Product capsules
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Oct 27, 2021

Therapeutic Equivalency Trial in Chennai (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Microgynon CD)

Completed
  • Therapeutic Equivalency
  • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
  • Microgynon CD
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
May 31, 2022

Autism Spectrum Disorder Trial in Staten Island (ML-004 (IR)/(ER) tablet)

Recruiting
  • Autism Spectrum Disorder
  • ML-004 (IR)/(ER) tablet
  • Staten Island, New York
    Richmond Behavioral Associates
Jun 1, 2023

Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • TALZENNA capsule
  • Talazoparib soft gel capsule
  • Encinitas, California
  • +31 more
Feb 14, 2022

Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita Trial in London (IMP Application KM-001, Physical Examination,

Recruiting
  • Punctate Palmoplantar Keratoderma Type 1
  • Pachyonychia Congenita
  • IMP Application KM-001
  • +14 more
  • London, Whitechapel Rd, United Kingdom
    Royal London Hospital-Clinical Research Facility-11D (11th Floor
Jul 23, 2023